v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jun. 27, 2020
Jun. 29, 2019
Operating activities:    
Consolidated net (loss) earnings $ (15,832) $ 4,436
Adjustment to reconcile net (loss) earnings to net cash used in operating activities:    
Depreciation and amortization 9,566 8,728
Amortization of deferred financing fees 233 234
Provision for (benefit from) allowances on accounts receivable 1,236 (287)
Provision for inventory market reserves 4,897 152
(Benefit from) provision for deferred income taxes (5,629) 225
Non-cash stock compensation 1,911 1,603
(Gain) loss on disposal of equipment (29) 18
Other, net (318) (1,642)
Changes in operating assets and liabilities, net of effect of acquisition    
Accounts receivable 7,784 (19,731)
Inventories, net 16,195 (1,821)
Prepaid expenses and other current assets 31 (236)
Other non-current assets (198) (71)
Accounts payable 2,957 209
Accrued expenses (1,899) (572)
Change in net operating lease liabilities 952 0
Income taxes (328) (136)
Other liabilities 462 344
Net cash provided by (used in) operating activities 21,991 (8,547)
Investing activities:    
Purchases of property and equipment, net (4,443) (4,211)
Cash paid for business (2,243) (4,599)
Net cash used in investing activities (6,686) (8,810)
Financing activities:    
Proceeds from long-term debt 312,251 356,141
Repayment of long-term debt (304,352) (330,359)
Repayment of capital financing (2,714) (3,041)
Payment of contingent consideration (2,500) (564)
Payment of deferred financing costs (1,079) 0
Repurchase of common stock (2,029) (2,796)
Payment of withholding taxes on stock awards (967) (2,113)
Net cash (used in) provided by financing activities (1,390) 17,268
Net increase (decrease) in cash and cash equivalents 13,915 (89)
Cash and cash equivalents at beginning of period 605 460
Cash and cash equivalents at end of period $ 14,520 $ 371

Source